185 related articles for article (PubMed ID: 33064947)
1. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ
García M; Virgili M; Alonso M; Alegret C; Farran J; Fernández B; Bordas M; Pascual R; Burgueño J; Vidal-Torres A; Fernández de Henestrosa AR; Ayet E; Merlos M; Vela JM; Plata-Salamán CR; Almansa C
J Med Chem; 2020 Dec; 63(24):15508-15526. PubMed ID: 33064947
[TBL] [Abstract][Full Text] [Related]
2. 4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ
García M; Virgili M; Alonso M; Alegret C; Fernández B; Port A; Pascual R; Monroy X; Vidal-Torres A; Serafini MT; Vela JM; Almansa C
J Med Chem; 2020 Mar; 63(5):2434-2454. PubMed ID: 31743642
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional μ opioid and σ
Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
[TBL] [Abstract][Full Text] [Related]
4. Discovery of DS34942424: An orally potent analgesic without mu opioid receptor agonist activity.
Arita T; Asano M; Kubota K; Domon Y; Machinaga N; Shimada K
Bioorg Med Chem; 2020 Nov; 28(21):115714. PubMed ID: 33065431
[TBL] [Abstract][Full Text] [Related]
5. Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σ
Zhuang T; Xiong J; Ren X; Liang L; Qi Z; Zhang S; Du W; Chen Y; Liu X; Zhang G
Eur J Med Chem; 2022 Nov; 241():114649. PubMed ID: 35961067
[TBL] [Abstract][Full Text] [Related]
6. Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ
García M; Llorente V; Garriga L; Christmann U; Rodríguez-Escrich S; Virgili M; Fernández B; Bordas M; Ayet E; Burgueño J; Pujol M; Dordal A; Portillo-Salido E; Gris G; Vela JM; Almansa C
J Med Chem; 2021 Jul; 64(14):10139-10154. PubMed ID: 34236190
[TBL] [Abstract][Full Text] [Related]
7. Optimization of bifunctional piperidinamide derivatives as σ
Xiong J; Zhuang T; Ma Y; Xu J; Ye J; Ma R; Zhang S; Liu X; Liu BF; Hao C; Zhang G; Chen Y
Eur J Med Chem; 2021 Dec; 226():113879. PubMed ID: 34628236
[TBL] [Abstract][Full Text] [Related]
8. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
[TBL] [Abstract][Full Text] [Related]
9. Thiophenpiperazine amide derivatives as new dual MOR and σ
Fan Z; Xiao Y; Shi Y; Hao C; Chen Y; Zhang G; Zhuang T; Cao X
Biochem Biophys Res Commun; 2024 Feb; 697():149547. PubMed ID: 38245926
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2
Turnaturi R; Pasquinucci L; Chiechio S; Grasso M; Marrazzo A; Amata E; Dichiara M; Prezzavento O; Parenti C
ACS Chem Neurosci; 2020 Apr; 11(7):999-1005. PubMed ID: 32186844
[TBL] [Abstract][Full Text] [Related]
11. Novel
Turnaturi R; Chiechio S; Pasquinucci L; Spoto S; Costanzo G; Dichiara M; Piana S; Grasso M; Amata E; Marrazzo A; Parenti C
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014375
[TBL] [Abstract][Full Text] [Related]
12. 2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance.
Fu K; Xu W; Yang R; Zhao H; Xu H; Wei Y; Liu H; Qiu Y; Chen D; Guo D; Xiong B
Eur J Med Chem; 2023 Mar; 249():115178. PubMed ID: 36753922
[TBL] [Abstract][Full Text] [Related]
13. Preliminary
Ayet E; Yeste S; Reinoso RF; Pretel MJ; Balada A; Serafini MT
Xenobiotica; 2021 May; 51(5):501-512. PubMed ID: 33622176
[TBL] [Abstract][Full Text] [Related]
14. Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.
Nastase AF; Anand JP; Bender AM; Montgomery D; Griggs NW; Fernandez TJ; Jutkiewicz EM; Traynor JR; Mosberg HI
J Med Chem; 2019 Apr; 62(8):4193-4203. PubMed ID: 30916966
[TBL] [Abstract][Full Text] [Related]
15. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D
Bonifazi A; Saab E; Sanchez J; Nazarova AL; Zaidi SA; Jahan K; Katritch V; Canals M; Lane JR; Newman AH
J Med Chem; 2023 Aug; 66(15):10304-10341. PubMed ID: 37467430
[TBL] [Abstract][Full Text] [Related]
17. Progress in the development of more effective and safer analgesics for pain management.
Turnaturi R; Chiechio S; Salerno L; Rescifina A; Pittalà V; Cantarella G; Tomarchio E; Parenti C; Pasquinucci L
Eur J Med Chem; 2019 Dec; 183():111701. PubMed ID: 31550662
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
Nakajima R; Yamamoto N; Hirayama S; Iwai T; Saitoh A; Nagumo Y; Fujii H; Nagase H
Bioorg Med Chem; 2015 Oct; 23(19):6271-9. PubMed ID: 26346669
[TBL] [Abstract][Full Text] [Related]
19. Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
Xiong J; Jin J; Gao L; Hao C; Liu X; Liu BF; Chen Y; Zhang G
Eur J Med Chem; 2020 Apr; 191():112144. PubMed ID: 32087465
[TBL] [Abstract][Full Text] [Related]
20. Novel Dual-Target μ-Opioid Receptor and Dopamine D
Bonifazi A; Battiti FO; Sanchez J; Zaidi SA; Bow E; Makarova M; Cao J; Shaik AB; Sulima A; Rice KC; Katritch V; Canals M; Lane JR; Newman AH
J Med Chem; 2021 Jun; 64(11):7778-7808. PubMed ID: 34011153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
